GREEN CROSS WellBeing Corporation Logo

GREEN CROSS WellBeing Corporation

Develops nutritional injections, health supplements, and cosmetics.

234690 | KO

Overview

Corporate Details

ISIN(s):
KR7234690006
LEI:
Country:
South Korea
Address:
서울특별시 영등포구 여의대로 108 파크원타워2 33층, 서울특별시

Description

GREEN CROSS WellBeing Corporation is a company focused on promoting human health through personalized nutrition solutions. Its primary business areas include the development and manufacturing of prescription nutritional injections, such as its placental injection Laennec. The company also provides a range of health functional foods and supplements, including the Dr. PNT brand, which offers customized nutrient solutions based on individual health needs and expert consultation. Further product lines include cosmetics derived from proprietary cell culture technology. Research and development is a key focus, with active programs in customized probiotics tailored to different life stages, the discovery of new functional materials from natural products, and the development of novel pharmaceutical treatments for conditions such as Cancer Cachexia.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2020-03-09 00:00
의결권대리행사권유참고서류
Korean 93.9 KB
2020-02-11 00:00
영업(잠정)실적(공정공시)
Korean 15.7 KB
2020-02-06 00:00
현금ㆍ현물배당결정
Korean 9.4 KB
2020-02-06 00:00
주주총회소집결의
Korean 14.3 KB
2020-01-06 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 23.5 KB
2019-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.4 KB
2019-10-21 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.1 KB
2019-10-21 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.1 KB
2019-10-21 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.1 KB
2019-10-21 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.1 KB
2019-10-21 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.1 KB
2019-10-21 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.1 KB
2019-10-21 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.2 KB
2019-10-21 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.1 KB
2019-10-21 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.2 KB

Automate Your Workflow. Get a real-time feed of all GREEN CROSS WellBeing Corporation filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GREEN CROSS WellBeing Corporation

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GREEN CROSS WellBeing Corporation via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

AVACTA GROUP PLC Logo
Clinical-stage biotech developing targeted oncology drugs with a proprietary platform.
United Kingdom
AVCT
AVADEL PHARMACEUTICALS PLC Logo
Biopharmaceutical company developing therapies for sleep disorders, focusing on narcolepsy.
United States of America
AVDL
Avalon GloboCare Corp. Logo
Develops cell-based immunotherapies and provides precision diagnostics and lab services.
United States of America
ALBT
Avidity Biosciences, Inc. Logo
Develops a class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs).
United States of America
RNA
Axogen, Inc. Logo
Develops and commercializes surgical solutions for peripheral nerve repair.
United States of America
AXGN
Axsome Therapeutics, Inc. Logo
A biopharmaceutical company developing therapies for central nervous system disorders.
United States of America
AXSM
AYTU BIOPHARMA, INC Logo
A specialty pharma company developing novel therapeutics for complex CNS diseases.
United States of America
AYTU
Azitra, Inc. Logo
Clinical-stage biopharma company developing microbiome-based therapies for skin diseases.
United States of America
AZTR
Bachem Holding AG Logo
A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.
Switzerland
BANB
Barinthus Biotherapeutics plc. Logo
Clinical-stage biopharma developing immunotherapies that guide T cells to control disease.
United States of America
BRNS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.